NYSE:FLO
NYSE:FLOFood

Assessing Flowers Foods (FLO) Valuation After New Protein Focused Nature’s Own Bread Launch

Flowers Foods (FLO) is drawing fresh attention after its Nature's Own brand introduced Life Wheat + Protein bread, a high protein, keto friendly loaf aimed at health focused shoppers seeking more protein and fiber. See our latest analysis for Flowers Foods. Despite the product launch, Flowers Foods’ share price has been under pressure, with a 90 day share price return showing a decline of 16.79% and a 1 year total shareholder return showing a decline of 41.93%. This suggests sentiment has...
NYSE:OKLO
NYSE:OKLOElectric Utilities

Oklo (OKLO) Valuation Check After Landmark Meta Nuclear Power Campus Deal

Oklo (OKLO) is back in focus after signing a landmark agreement with Meta Platforms to develop a 1.2-gigawatt advanced nuclear power campus in Ohio. The facility will supply electricity to Meta’s expanding AI data center operations. See our latest analysis for Oklo. Oklo’s share price has been volatile, with a 1 day share price return of 5.28% decline, a 30 day share price return of 11.06% and a year to date share price return of 24.79%. The 1 year total shareholder return of 325.65% and 3...
NasdaqGS:DASH
NasdaqGS:DASHHospitality

Is DoorDash’s Dollar-Store Push Reframing Its Affordability Strategy and Competitive Moat (DASH)?

DoorDash recently announced a partnership with Family Dollar to deliver household essentials from roughly 7,000 stores, emphasizing lower fees and expanded access for SNAP/EBT users to better serve price‑sensitive customers. This move highlights DoorDash’s effort to strengthen its position among lower‑income households by pairing dollar‑store pricing with targeted affordability initiatives on its platform. Now we’ll explore how this push into dollar‑store delivery and affordability programs...
SWX:TECN
SWX:TECNLife Sciences

Tecan Group (SWX:TECN) Posts Flat H2 Local-Currency Sales Is Its Recovery Story Credible?

Tecan Group AG has released unaudited preliminary results for fiscal 2025, reporting second-half sales growth of 0.4% in local currencies but a 5.2% decline in Swiss francs to CHF 443.0 million, with full-year sales down 1.6% in local currencies and 5.5% in Swiss francs to CHF 882.5 million versus 2024. The return to modest second-half growth, despite a full-year sales contraction, highlights a possible turning point in demand momentum amid currency headwinds and lingering operational...
NYSE:WT
NYSE:WTCapital Markets

How Record US$143 Billion AUM and Precious Metals Inflows At WisdomTree (WT) Has Changed Its Investment Story

In December 2025, WisdomTree, Inc. reported record global exchange traded product and tokenized assets under management of about US$143 billion, with US$1.10 billion of net inflows for the month and US$8.50 billion for 2025, largely driven by gold and other precious metals. This strong organic growth in assets and flows highlights how investor demand for WisdomTree’s ETFs and tokenized products is reinforcing its broader expansion across both traditional and digital investment...
TSX:BAM
TSX:BAMCapital Markets

Is Brookfield Asset Management (TSX:BAM) Pricing In Too Much Optimism After Strong Three Year Run

If you are wondering whether Brookfield Asset Management is attractively priced right now, the key question is how its current share price lines up with a fair value estimate. The stock recently closed at C$72.85, with returns of a 4.3% decline over the last week, a 1.6% decline over the last month, a 0.7% decline year to date, and a 1.1% decline over the last year, while the 3 year return stands at 89.6%. Recent headlines around Brookfield Asset Management have focused on its role as a...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

Is Vertex Pharmaceuticals (VRTX) Still Attractive After CASGEVY Progress And A Higher P/E Ratio

If you are wondering whether Vertex Pharmaceuticals at around US$454.67 is still a reasonable entry or more of a hold, you are asking the right question for a valuation check. The stock's returns sit at 0.6% over the last month and year to date, 10.4% over 1 year, 45.7% over 3 years and 96.1% over 5 years, which naturally raises questions about how much of the story is already reflected in the price. Recent attention on Vertex has centered on its pipeline progress and its role in high...